Acute Myeloid Leukemia in Adults

We offer compassionate care throughout the diagnosis and treatment of acute myeloid leukemia, a rapidly growing cancer of blood-forming cells in the bone marrow, the spongy tissue in the center of bones. Our hematologist–oncologists use the latest diagnostic tools, such as molecular profiling and chromosome analysis, to create a personalized treatment plan for you. Our goal is to manage this cancer quickly with the goal of achieving remission, in which cancer cells are no longer detected in the blood.

Meet Our Doctors

Diagnosis

Diagnosing Acute Myeloid Leukemia in Adults

Chemotherapy

Intrathecal Therapy

Stem Cell Transplantation

Clinical Trials and Research Studies

Phase 2

Open-label Multicenter Phase 2 Study Evaluating the Efficacy & Safety of Daratumumab in Pediatric & Young Adult Subjects =1 & =30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Learn More

Phase 3

EA9161: A Randomized Phase III Study of the addition of Venetoclax to Ibrutinib and Obinutuzumab versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

Learn More

Phase 3

Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia

Learn More

Phase 1/2

Relapsed or Refractory Acute Myeloid Leukemia: Venetoclax and Alvocidib

Learn More

View All Related Clinical Trials (11)